JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Originally published In Press as doi:10.1074/jbc.M701841200 on April 9, 2007

J. Biol. Chem., Vol. 282, Issue 24, 17816-17827, June 15, 2007
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
282/24/17816    most recent
M701841200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Abe, Y.
Right arrow Articles by Ueda, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Abe, Y.
Right arrow Articles by Ueda, T.
Related Collections
Right arrow Papers Of The Week
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Structure and Function of DnaA N-terminal Domains

SPECIFIC SITES AND MECHANISMS IN INTER-DnaA INTERACTION AND IN DnaB HELICASE LOADING ON oriC*Formula {diamondsuit}

Yoshito Abe{ddagger}, Takaaki Jo§1, Yusaku Matsuda§, Chika Matsunaga§, Tsutomu Katayama§2, and Tadashi Ueda{ddagger}3

From the Departments of {ddagger}Immunology and §Molecular Biology, Graduate School of Pharmaceutical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan

Received for publication, March 2, 2007 , and in revised form, April 6, 2007.


   ABSTRACT
TOP
 ABSTRACT
INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
DnaA forms a homomultimeric complex with the origin of chromosomal replication (oriC) to unwind duplex DNA. The interaction of the DnaA N terminus with the DnaB helicase is crucial for the loading of DnaB onto the unwound region. Here, we determined the DnaA N terminus structure using NMR. This region (residues 1–108) consists of a rigid region (domain I) and a flexible region (domain II). Domain I has an {alpha}-{alpha}-beta-beta-{alpha}-beta motif, similar to that of the K homology (KH) domain, and has weak affinity for oriC single-stranded DNA, consistent with KH domain function. A hydrophobic surface carrying Trp-6 most likely forms the interface for domain I dimerization. Glu-21 is located on the opposite surface of domain I from the Trp-6 site and is crucial for DnaB helicase loading. These findings suggest a model for DnaA homomultimer formation and DnaB helicase loading on oriC.


   INTRODUCTION
TOP
 ABSTRACT
 INTRODUCTION
EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
In Escherichia coli, DnaA initiates the replication of genomic DNA in a cell cycle-coordinated manner (1, 2). The initiation complex contains a homomultimer of DnaA protein and the replication origin, oriC, of the chromosome. DnaA binds cooperatively to the oriC region in a manner depending on tight binding to the DnaA box sequences within the oriC region. The initiation complex containing ATP-bound DnaA molecules unwinds the duplex of the AT-rich 13-mer repeats within oriC, forming an open complex. This leads to the loading of DnaB helicase onto single-stranded DNA (ssDNA)4 in the presence of the DnaC helicase loader. In this process, the interaction between DnaA and DnaB is crucial. DnaA creates a specific nucleoprotein structure within which ordered structural DNA changes and protein-protein interactions take place. DnaG primase then complexes with the ssDNA-loaded DnaB, which leads to DNA chain synthesis by the DNA polymerase III holoenzyme. The DNA-loaded beta-clamp subunit of the holoenzyme complexes with Hda, a DnaA paralogue protein, and this complex promotes DnaA-ATP hydrolysis, yielding inactive ADP-DnaA (3–5).

DnaA is a 52-kDa basic protein that has four distinct functional domains (1, 2). NMR and crystal structure analyses have revealed that C-terminal domain IV of E. coli DnaA has a helix-turn-helix motif, which binds the DnaA box specifically (6–8). DnaA domain III contains ATP binding/hydrolysis motifs of the AAA+ ATPase family (9–14). Erzberger et al. (9) proposed an oligomeric structure for DnaA based on crystal structures of the ATP- and ADP-bound forms of DnaA domains III–IV from the hyperthermophilic bacterium Aquifex aeolicus. In this model of the initiation complex, the ATP-DnaA molecules assemble in a head-to-tail manner, and the resultant oligomers form a spiral helix, consistent with the known features of the AAA+ family proteins (11, 15). The structure-function relationships of the N-terminal domains I and II of DnaA remain obscure.

The amino acid sequence of domain I (residues 1–86 in E. coli DnaA; Fig. 1A) is highly conserved among DnaA homologs of eubacterial species, unlike that of domain II (residues 87–134 in E. coli DnaA) (2). The structure of domain II is suggested to be a flexible linker, part of which is dispensable for DnaA function. Domain I functions in DnaA oligomerization and DnaB helicase loading. A deletion analysis of domain I suggest that a region containing residues 1–77 carries a crucial site for DnaA oligomerization (16). The DnaA W6A mutant protein is inactive in initiation, whereas its affinities for oriC and ATP/ADP are sustained (17, 18). Chemical linking experiments suggest that the activity to form oligomers is somehow reduced in this mutant protein. The mechanism of interdomain I interaction remains unclear.

DnaA directs DnaB loading onto the ssDNA region in the presence of DnaC (19). Analyses of domain I-truncated mutants suggest that a region containing residues 1–62 is required for direct binding to DnaB during the loading process (20), whereas the region containing residues 24–86 is required for physical contact with DnaB (21). The specific residues required for DnaB loading remain to be determined. In addition, DnaB loading activity is prevented by anti-DnaA antibodies that specifically bind to the domain III N terminus (residues 111–148) (22, 23). DnaB interaction sites in domain I and domain II may play specific roles in the steps for DnaB loading (20, 21). In eukaryotic genome replication, the origin recognition complex interacts with the MCM helicase (24), suggesting that the interaction of an origin-binding protein with a helicase is a conserved principal mechanism of the initiation process. However, the precise mechanisms of the initiator-helicase interaction and helicase loading remain to be elucidated. To reveal these mechanisms, the structure of the DnaA N-terminal domain and the structure-function relationship within this domain have to be determined.

In the present study, we determined the structure of the E. coli DnaA N terminus (residues 1–108) using NMR analysis. We found a unique residue, Glu-21, that is crucial and specific for DnaB loading. Furthermore, we have demonstrated that domain I carries weak affinity for ssDNA carrying the AT-rich 13-mer within oriC but not for poly(dT) ssDNA. Based on these findings, we propose a novel model of DnaA homo-oligomer formation and DnaB helicase loading, in which a hydrophobic surface containing Trp-6 forms homodimers between the DnaA domain I regions within the larger DnaA multimer, thereby exposing Glu-21 for DnaB binding.


   EXPERIMENTAL PROCEDURES
TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
RESULTS
 DISCUSSION
 REFERENCES
 
Protein Preparation of the DnaA N terminus—A 5'-region of the wild-type dnaA corresponding to amino acid residues 1–128 was amplified by PCR. The amplified DNA fragment was ligated into the vector pET-22b(+) (Novagen), and introduced into E. coli BL21(DE3). For the preparation of labeled protein, the transformed cells were cultured in M9 minimal medium containing 15NH4Cl and 13C-labeled glucose. The DnaA N terminus (residues 1–128) was overexpressed from E. coli by induction with isopropyl 1-thio-beta-D-galactopyranoside, and the cells were suspended in chilled buffer (50 mM Tris-HCl (pH 8.0), 1 mM EDTA, 1 M KCl, 2 mM dithiothreitol, 20 mM spermidine-HCl, and 10% sucrose), incubated on ice for1hinthe presence of 0.2 mg/ml lysozyme, and frozen in liquid nitrogen. The frozen cell suspension was melted on ice and centrifuged at 17,000 rpm for 40 min. The resultant supernatants were dialyzed against buffer A (50 mM Tris-HCl (pH 8.0), 20 mM EDTA, 40 mM KCl, 2 mM dithiothreitol, and 10% sucrose) and loaded onto Toyopearl DEAE-650 M (Tosoh Co.) and Toyopearl CM-650M. The DnaA N terminus was collected in the follow-through fractions after both chromatography. The collected proteins were precipitated by salting-out, using 80% ammonium sulfate. Proteins were subjected to chromatography on Sephadex G-75 with buffer A as the eluent. The typical yield of the DnaA N terminus was 9 mg of protein/liter of M9 medium. Partially proteolysis of flexible region was often improved the NMR spectrum for structural determination of protein (25). To partially proteolyze the purified DnaA N terminus, it was treated with L-1-tosylamido-2-phenylethyl chloromethyl ketone-trypsin (5000:1 w/w) at 4 °C for 12 h. This proteolysis yielded the truncated N terminus (residues 1–108), which was confirmed using MALDI-TOF MS (matrix-assisted laser desorption ionization time-of-flight mass spectroscopy). This truncated DnaA N terminus was further subjected to chromatography on Toyopearl DEAE-650M. Protein in the follow-through solutions was precipitated by salting-out using 80% ammonium sulfate, dissolved in and dialyzed against buffer A, and stored at -20 °C.

NMR Measurements and Structural Calculations—The NMR spectra were recorded at 25 °C on a Varian Unity INOVA 600 spectrometer. NMR samples (0.8 mM) of the DnaA N terminus were dissolved in buffer B (50 mM sodium phosphate (pH 6.5), 20 mM EDTA, 40 mM KCl, 2 mM dithiothreitol, and 10% sucrose) containing 100% D2O or 90% H2O, 10% D2O. A series of three-dimensional double and triple resonance experiments (HNHA, HNCA, HN(CO)CA, HNCBCA, CACBCONH, HNCO, HN(CA)CO, (H)CC(CO)NH, HCCH-TOCSY, HCCH-COSY, and 15N-edited TOCSY) were recorded for the spectrum assignments of the DnaA N terminus.

For the structural determination, the stereospecific assignments of the methyl groups of the leucine and valine residues were obtained from the 1H-13C HSQC spectrum recorded on a 13C biosynthetically directed labeled sample (26). The pulse sequence used to measure the 1H–15N heteronuclear NOEs (nuclear Overhauser enhancements) was described by Grezeiek and Bax (27). The NOE data from the DnaA N terminus (residues 1–108) were obtained from 1H NOESY and 15N- or 13C-edited NOESY experiments carried out with a mixing time of 150 ms. NMRPipe (28) was used to process the data and to assign the resonance peaks. The assignments of the resonance peaks of each amino acid residue were carried out using Olivia (fermi.pharm.hokudai.ac.jp). CYANA (version 2.1) (30) was used to calculate the structures. A total of 107 {phi} and {Psi} values were estimated on the basis of the HN, C', C{alpha}, and Cbeta chemical shifts using TALOS (31). The distance constraints of the hydrogen bonds were incorporated based on the results of an experiment involving slowly exchanging amide protons. The restraints used for the structural calculations are summarized in Table 1. A total of 200 structures were finally obtained, and the mean coordinates were obtained by averaging the coordinates of the 20 structures with the lowest energy. Ramachandran analysis was performed by the PROCHECK program (32). Structure figures were generated using PyMOL (www.pymol.org) and MOLMOL (34). The domain I structure and poly(C)-binding protein 2 (PCBP2) were superimposed using the Insight II package (Accelrys Inc.). The coordinates used for the ensemble of NMR structures have been deposited in the PDB under accession code 2E0G. The tables have been deposited in BioMagResBank (www.bmrb.wisc.edu) under accession number 10027.


View this table:
[in this window]
[in a new window]

  		TABLE 1
Summary of structural statistics obtained for the DnaA N terminus Statistics were derived from a set of 20 low-energy structures, each obtained by simulated annealing and derived from a unique starting model. Ramachandran analysis was performed using the PROCHECK program (32).

 
ssDNA and Salt Titration—The 28-mer ssDNA (5'-GATCTGTTCTATTGTGATCTCTTATTAG-3') bearing the oriC 13-mer repeats and the 28-mer poly(dT) were purchased (Invitrogen) and purified before conducting NMR titration. We recorded the 1H-15N HSQC (heteronuclear single quantum correlation) spectra of 0.1 mM 15N-labeled protein in the presence of various concentrations of KCl (up to 160 mM) or of the indicated ssDNA (up to 0.6 mM). The respective concentrations of the proteins and the oligonucleotides or salt were corrected for dilution. The overall volume changes amounted to less than 10%.

Construction, Purification, and Functional Assays of the Site-specifically Mutated DnaA—Mutant DnaA proteins were constructed by a site-directed mutagenesis method as we described previously (12, 13). The sequences of the mutagenic primers used are listed in supplemental Table 1. The overexpression, purification, and assays of nucleotide binding activities and minichromosomal replication activities using a crude replicative extract and a system reconstituted with purified proteins, P1 nuclease assay, and ABC primosome assay were performed as we described previously (12, 13, 35).


Figure 1
View larger version (22K):
[in this window]
[in a new window]

  		FIGURE 1.
The E. coli DnaA N terminus and NMR analysis. A, the amino acid sequence of E. coli DnaA N-terminal region. Residue numbers are indicated above the sequence. B, the secondary structure determined in this study. C, sequence dependence of 1H-15N NOE values. Peak intensity ratios (Ion/Ioff) less than 0.6 suggest flexible structures. The red line represents a peak intensity ratio of 0.6.

 
The form I* formation assay was performed as described by Marszalek et al. (23) with minor modifications. Briefly, DnaA was incubated at 30 °C for 30 min in buffer (25 µl) containing 20 mM Tris-HCl (pH 7.5), 0.1 mg/ml bovine serum albumin, 8 mM dithiothreitol, 10 mM Mg(OAc)2, 125 mM potassium glutamate, 2 mM ATP, 2.32 µg of single strand-binding protein (SSB), 2.5 ng of HU protein, 150 ng of DnaB, 92 ng of DnaC, 180 ng of DNA gyrase A subunit, 225 ng of DNA gyrase B subunit, and 200 ng of M13KEW101 minichromosome. The reaction was stopped in the presence of SDS and EDTA followed by 0.7% agarose gel electrophoresis.

A reconstituted, staged regulatory inactivation of DnaA (RIDA) reaction system was used basically as described previously (5, 36), except that we used Hda tagged with His6 at the C terminus.5 Briefly, the clamps (100 pmol as dimer) were incubated at 30 °C for 20 min in 25 µl of buffer C (20 mM Tris-HCl (pH 7.5), 10% glycerol, 8 mM dithiothreitol, 0.01% Brij-58, 8 mM Mg(OAc)2, and 150 mM potassium glutamate) containing 1 mM ATP, 94 ng of {gamma}-complex and M13mp18 replicative form II (1 µg). The resulting DNA-loaded clamps were isolated using a Sephacryl S-400 HR spin column (0.9 ml) equilibrated with buffer C. In the second stage, the indicated amounts of the isolated DNA-loaded clamps were incubated at 30 °C for 20 min in buffer containing 20 mM Tris-HCl (pH 7.5), 10% glycerol, 8 mM dithiothreitol, 0.01% Brij-58, 8 mM Mg(OAc)2, 120 mM potassium glutamate, 2 mM ATP, 0.1 mg/ml bovine serum albumin, 56 fmol of the C-terminally His-tagged Hda, and [{alpha}-32P]ATP-DnaA (0.25 pmol). Nucleotides bound to DnaA were recovered by filter retention, separated by thin-layer chromatography, and quantified by a BAS2500 bioimaging analyzer (Fuji Film).


   RESULTS
TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
DISCUSSION
 REFERENCES
 
The Structure of the DnaA N Terminus—To determine the structure of the DnaA N terminus using NMR analysis, we labeled amino acid residues 1–108 with 15N and recorded the 1H-15N HSQC spectrum at 25 °C and pH 6.5. The spectrum included separated and dispersed peaks. Therefore, we assigned the 1H, 15N, and 13C chemical shifts of the DnaA N terminus using a double-labeled sample and heteronuclear three-dimensional NMR. We were able to assign most signals in the DnaA N terminus except for residues 1–3 (BioMagResBank accession number 10027).

We carried out 1H-15N heteronuclear NOE measurements based on the assignment of the chemical shifts. Because the peak intensity ratios (Ion/Ioff) in the domain I region (residues 1–78) are more than 0.8 (Fig. 1C), domain I appears to have a rigid structure in solution. In contrast, the peak intensity ratios (Ion/Ioff) in a region including a short portion of the domain I C terminus and domain II (residues 79–108) were less than 0.6 (Fig. 1C), indicating that this region is flexible and disordered. Additionally, we did not see long-range homonuclear 1H-1H NOEs in the domain II region. Therefore, we divided the DnaA N terminus into two distinct domains, a rigid domain I and a disordered domain II.

We calculated the structure of the DnaA N terminus (residues 1–108) on the basis of a total of 814 NOE-derived interproton distances, 61 hydrogen bonds that originated from slowly exchanging amides, and 107 {phi} and {Psi} dihedral angle constants that were obtained from calculations using the TALOS program (31) (Table 1). A total of 200 structures were calculated, and the 20 lowest energy structures were selected and subjected to restrained energy minimization. The final 20 structures were superimposed on the mean coordinate position for the backbone atoms (N, Ca, C') of residues 5–78 of DnaA (Fig. 2A). The r.m.s.d. from the mean coordinate position was 0.24 Å for well defined backbone atoms of residues. These calculated parameters are summarized in Table 1.

The structure of the DnaA N terminus (residues 1–108) consisted of three beta-strands (beta1 (residues 31–34), beta2 (38–41), and beta3 (73–78)), three {alpha}-helices ({alpha}1 (5–16), {alpha}2 (21–25), and {alpha}3 (47–62)), and a following long, flexible C terminus (Fig. 1, B and C). The 1H-15N heteronuclear NOE results were consistent with the well defined secondary structure regions obtained from our calculations (Fig. 1C). beta1 and beta2 form an anti-parallel beta-sheet, and beta2 and beta3 form a parallel beta-sheet (Fig. 2B). The {alpha}3-helix is kinked at Tyr-55. In a hydrogen-deuterium (H-D) exchange experiment, the amide signals from Lys-54 to Asn-58 were not remained (data not shown); that is, the hydrogen bonds from Lys-54 to Asn-58 were disrupted, supporting the kinked helix. The hydrophobic core of domain I consists of Cys-9, Leu-13, Phe-22, Ile-26, Leu-29, Leu-38, Leu-40, Val-51, Tyr-55, and Ile-59 (Fig. 2C; see supplemental Fig. 1 online). These hydrophobic residues are conserved in DnaA homologs in eubacterial species (supplemental Fig. 2), suggesting that the overall conformation of domain I is evolutionarily conserved.

We searched the DALI server (37) for proteins that are structurally similar to DnaA domain I (residues 1–78). The K homology (KH) domain had a high Z-score, indicating that its structure is very similar to that of DnaA domain I. The KH domains have two distinct motifs of secondary structure, type I and type II, although the folds are similar to each other (38). The Dali server reported the similarity of DnaA domain I to any of type II KH domain, as DnaA domain I has an {alpha}-{alpha}-beta-beta-{alpha}-beta motif. The fold of domain I is similar to that of the type I KH domain as well as that of the type II KH domain (Fig. 2D).

Dimerization of Domain I—The KH domain is reported to form homodimers via hydrophobic interaction (39). Therefore, we focused on the hydrophobic interaction between DnaA domain I monomers. The hydrophobic interaction is enhanced at higher salt concentrations. We observed that the chemical shift changes of several peaks of domain I occurred as the KCl concentration was increased to a level near the physiological salt concentration (Fig. 3). The 1H-15N HSQC spectra of the 15N-labeled DnaA N termini overlap in the presence of 40 mM or 160 mM KCl (Fig. 3A). Residues causing chemical shift changes of more than 0.02 ppm were concentrated in the N-terminal {alpha}1-helix and the loop between beta1 and beta2 (Fig. 3, B and C). Representatives of such residues are Leu-5, Trp-6, Leu-10, and Leu-33, which are exposed on the surface and form a hydrophobic patch (Fig. 3C). DnaA Trp-6 is crucial for weak interactions between DnaA molecules detected in chemical cross-linking experiments (17, 18). Therefore, the observed chemical shift changes supported the idea that a pair of domain I monomers forms a homodimer using the hydrophobic patch as an interface (Fig. 3D).

Domain I Has a Weak Affinity for the oriC 13-Mer ssDNA but Not for Poly(dT) ssDNA—The KH domain was first characterized biochemically in heterogeneous nuclear ribonucleoprotein K (hnRNP K), a major pre-mRNA-binding protein K, and has since been detected in a number of RNA-binding proteins (40, 41). PCBP2 contains several KH domains that specifically and directly interact with telomere poly(dC) ssDNA (39, 42). Therefore, we used NMR to investigate whether DnaA domain I interacts with ssDNA.

A 28-mer ssDNA bearing the oriC 13-mer sequence caused chemical shift changes in the 1H-15N HSQC spectra of the 15N-labeled DnaA N terminus (residues 1–108; Fig. 4A). As the ssDNA concentration increased to a molar ratio greater than 1:6, several signals were shifted. From the chemical shift changes of these peaks, we estimated the Kd to be ~1 mM (in concentration of the DNA fragment) (Fig. 4B). These results suggest that DnaA domain I has weak affinity for ssDNA carrying the 13-mer sequence. We also plotted the chemical shift changes as a function of the residue number of DnaA at 0.6 mM ssDNA (Fig. 4C). The residues causing chemical shift changes of more than 0.02 ppm are localized in the N-terminal half of the {alpha}3-helix and the loop between {alpha}1 and {alpha}2, a region including Glu-21 (Fig. 4, D and E). Unlike the oriC 13-mer ssDNA, poly(dT) ssDNA did not cause any chemical shift changes (Fig. 4B and supplemental Fig. 3), suggesting that the affinity of domain I for ssDNA is associated with at least some sequence specificity.


Figure 2
View larger version (32K):
[in this window]
[in a new window]

  		FIGURE 2.
Solution structure of the DnaA N terminus. A, stereo view of superposition of 20 simulated annealing structures of the DnaA N terminus (residues Met-1—Thr-80, PDB code 2E0G). B, ribbon model of the DnaA N terminus represented as three {alpha}-helices ({alpha}1 (residues 5–16), {alpha}2 (21–25), and {alpha}3 (47–62)) and three beta-sheets (beta1 (31–34), beta2 (38–41), and beta3 (73–78)). C, the hydrophobic residues are represented in green on the ribbon model of the DnaA N terminus. D, superposition of DnaA N terminus (type II KH domain, colored blue) and PCBP2 (PDB code: 2AXY; type I KH domain, colored red). Superposition was performed using the Insight II package (Accelrys Inc.). The regions used in r.m.s.d. minimization were beta1, beta2, {alpha}3, and beta3 in the DnaA N terminus and beta1, {alpha}1, {alpha}2, beta2, and beta3 in PCBP2, respectively. The root mean square deviation is 3.5 Å.

 


Figure 3
View larger version (37K):
[in this window]
[in a new window]

  		FIGURE 3.
The salt-sensitive surface of the DnaA N terminus. A, part of the 1H-15N HSQC spectrum of the DnaA N terminus showing the chemical shift changes for specific amino acids (Leu-5, Trp-6, and Leu-13 are noted) in the presence of 40 mM (black) or 160 mM KCl (red). B, differences in 1H chemical shift changes between the presence of 40 and 160 mM KCl are displayed for the backbone amides as a function of the sequence number. The red line represents a shift of 0.02 ppm. C, surface representation of the salt-sensitive residues on the ribbon model of DnaA N terminus. The hydrophobic residues comprising the salt-sensitive surface are represented by the green color. D, dimer model of the DnaA N terminus. Based on the dimer structure of PCBP2 (PDB code: 2AXY). The beta1-strand is located on the dimer interface, and each monomer is placed as rotational symmetry. A hydrophobic patch determined in the experiment described in C is also located on the dimer interface. The ssDNA-binding sites (red) and salt-sensitive and hydrophobic sites (green) are located on opposite sides of the molecular surface.

 
Construction and Solubility of Novel DnaA Domain I Mutants—Based on the solution structure and sequence homology of domain I, we selected sites within domain I to mutate for a functional analysis. First, we individually replaced Arg-12, Gln-14, Asp-15, Glu-16, Glu-21, Asn-44, Arg-45, Phe-46, and Lys-54 with alanine using pKA234, an arabinose-inducible DnaA-overproducing plasmid (12, 13). These residues are exposed on the protein surface in solution (Fig. 5; supplemental Fig. 1), and some are structurally affected by ssDNA (Fig. 4D). Next, we replaced with alanine the residues that are highly conserved in DnaA orthologues of eubacterial species bearing Hda orthologues (supplemental Fig. 2). Trp-6, Leu-13, and Leu-17 were individually mutated. Residues 25–27, 28–30, and 40–43 were replaced with the corresponding number of alanine residues.

Each DnaA protein was overexpressed at 37 °C, and soluble lysates were prepared (12, 13, 43). All of the DnaA proteins bearing substitutions of surface residues were obtained from soluble fractions at a level similar to the wild-type DnaA, except that the solubility of DnaA N44A and K54A was slightly reduced (supplemental Fig. 4A). In contrast, all of the other mutant proteins (DnaA W6A, L13A, L17A, 25–27A, 28–30A, and 40–43A) were poorly soluble (supplemental Fig. 4B). Substitution of these evolutionarily conserved residues most likely affected the whole structure of domain I, leading to denatured aggregates. Indeed, considerable parts of the side chains of Trp-6, Leu-13, Leu-17, Trp-25, Ile-26, Leu-29, and Leu-40 are located inside of the domain I structure (Fig. 2C; supplemental Fig. 1). Consistent with this, DnaA L38A, L40A, and I59A proteins are reported to rapidly degrade in cells (17). The side chains of Leu-38 and Ile-59 are also located inside of the solution structure determined in this study (Fig. 2C; supplemental Fig. 1). Thus, the solution structure can reasonably explain all of these observations.

DnaA E21A Is Inactive in Vivo—To determine the in vivo activity of the soluble DnaA domain I mutant proteins, we preformed dnaA complementation experiments using strain KA451, which carries dnaA::Tn10 rnhA::cat double mutations. Lack of the rnhA gene activates alternative replication origins and induces DnaA-independent replication of the chromosome. The doubling time of KA451 cells is at about 200 min at 37 °C; visible colonies do not form on LB-glucose agar plates for more than 20 h. Introduction of plasmid bearing the wild-type dnaA gene into this strain enhances the growth rate and the colony formation. After transformation with dnaA allele-carrying plasmids, we deduced the numbers of colonies formed during incubation for 21 and 37 h and calculated the ratio (Table 2). This ratio is 0.5–5 for KA451 bearing the wild-type dnaA. We also introduced mutant dnaA alleles. The dnaA E21A allele did not increase the rate of colony formation (Table 2). An immunoblot analysis indicated that the stability of this mutant protein in vivo was similar to that of the wild-type DnaA (data not shown). These results indicate that the initiation activity of DnaA E21A is severely impaired in vivo. In addition, the initiation activities of DnaA Q14A and E16A proteins might be slightly inhibited in vivo (Table 2). We therefore further analyzed DnaA E21A, Q14A, and E16A proteins in vitro.


View this table:
[in this window]
[in a new window]

  		TABLE 2
DnaA activity assay in vivo Strain KA451 (dnaA::Tn10 rnhA::cat) was transformed with plasmid bearing the indicated dnaA allele and incubated at 37 °C for the indicated times on LB-agar plates containing 0.2% glucose and 100 µg/ml ampicillin. The numbers of colonies formed during incubation for each time and the ratio are shown.

 


Figure 4
View larger version (32K):
[in this window]
[in a new window]

  		FIGURE 4.
ssDNA binding ability of the DnaA N terminus. A, the 1H-15N HSQC spectrum of the DnaA N terminus showing the chemical shift changes in the absence (black) and presence (red) of 0.6 mM 28-mer ssDNA bearing the oriC 13-mer sequences (5'-GATCTGTTCTATTGTGATCTCTTATTAG-3'). An enlargement of the selected region is shown in the inset. B, NMR titration of the ssDNA to the DnaA N terminus. ssDNA binding was assessed by the change in the NMR chemical shift of amide proton peak of Phe-46 in 1H-15N HSQC. The titration curve was analyzed by a nonlinear iterative fitting procedure, and the dissociation constant, Kd, was estimated to be ~1mM. Open circles, 28-mer ssDNA bearing the oriC 13-mer sequences; closed triangles, 28-mer poly(dT) ssDNA. C, differences in the chemical shift changes between the absence and presence of ssDNA are displayed for the backbone amides as a function of sequence number. All chemical shifts changes in the 1H-15N HSQC spectra were calculated according to the formula [{Delta}{delta}(1H)2+ ({Delta}{delta}(15N)/7)2]1/2. The red and orange lines represent 0.03 and 0.02 ppm, respectively. D, ribbon models of the DnaA N terminus indicating residues that experience ssDNA-induced chemical shift changes. The residues represented by stick models are those that underwent chemical shift changes more than 0.03 ppm (red) or 0.02 ppm (orange). E, structural comparison between the KH domain and domain I of DnaA. The structures of the PCBP2-ssDNA complex (PDB code: 2AXY; right panel) and domain I of DnaA (left panel) are shown. Each structure is shown as a ribbon model. Single-stranded DNA is shown as gray stick models. Red, blue, and green represent acidic, basic, and hydrophobic amino acids, respectively. The glycines in the GXXG motif of PCBP2 are colored yellow. To show the bulkiness of the side chains in domain I, acidic and basic amino acids are represented by stick models (left panel).

 


Figure 5
View larger version (35K):
[in this window]
[in a new window]

  		FIGURE 5.
The surface of the DnaA N terminus and the residues analyzed. The structure of the DnaA N terminus is shown as a space-filling model on which amino acids at sites of mutations are plotted. The color scheme for the mutants is as follows: red, acidic residues; blue, basic residues; green, hydrophobic residues; magenta, polar residues.

 
Purification of Mutant DnaA and Assessment of Its Nucleotide Binding and Replication Activities—DnaA Q14A, E21A, and E16A proteins were overproduced and purified using a method that we previously used for the wild-type DnaA and other mutant DnaA proteins (12–14). The purity of the proteins was >90% (supplemental Fig. 4C). In a filter retention assay, these mutant DnaA proteins substantially had the same affinity for ATP and ADP as the wild type (Table 3).


View this table:
[in this window]
[in a new window]

  		TABLE 3
Affinity for ATP/ADP Purified wild-type and mutant DnaA proteins were assessed for nucleotide binding activity using a filter retention assay. Means ± S.D. was calculated based on the results of three independent experiments.

 
Using a minichromosomal replication system reconstituted with purified proteins (4, 12, 13, 35), we assessed the initiation activities of mutant DnaA (Fig. 6, A–C). DnaA Q14A and E16A retained initiation activity close to that of the wild type, but the activity of DnaA E21A was severely inhibited (Fig. 6A). Similar results were observed even when the protein was complexed with ATP prior to the replication reaction (Fig. 6B) or when the time for replication was elongated (Fig. 6C).

When a crude replicative fraction was used for in vitro minichromosomal replication, DnaA E21A was also somewhat inhibited, but significant residual activity was retained (Fig. 6D). Chaperone proteins included in the crude fraction might stimulate DnaA E21A activity (44, 45).

DnaA E21A Is Active in ATP-dependent Open Complex Formation—To determine the role of Glu-21 in initiation, we assessed open complex formation using the oriC plasmid M13KEW101 and P1 nuclease (12, 13). P1 nuclease breaks DNA specifically at single-stranded sites. If the oriC site of M13KEW101 is specifically broken by P1 nuclease, subsequent digestion with the AlwNI restriction enzyme will produce 3.8- and 4.1-kb fragments (Fig. 7A). The ATP form of the DnaA E21A protein formed open complexes, and the ADP form was inactive similar to the wild-type forms (Fig. 7, A and B), although the maximum level of open complex formation by ATP-DnaA E21A was about half that of the wild-type ATP form across the limited range of DnaA concentrations we examined.

DnaA E21A Is Defective in DnaB Helicase Loading—In the initiation process, DnaB helicase loading is the next step of open complex formation. To investigate the role of Glu-21 in this step, we first used an in vitro ssDNA replication system with the ABC primosome (12, 13, 19). The template in this system is ssDNA with a local hairpin structure bearing a DnaA box. Initiation of replication depends on DnaB loading directed by DnaA bound to the hairpin in the presence of DnaC. DnaA E21A had severely limited activity in ABC primosome-dependent replication (Fig. 7, C and D), indicating that this protein has a defect in DnaA-directed DnaB loading.

Next, we assessed DnaB helicase loading onto oriC. When DnaB helicase is loaded onto the open complex of oriC, successive unwinding by the helicase produces a specifically super-coiled form called form I* in the presence of DNA gyrase activity (23, 46). Unlike the wild-type DnaA, DnaA E21A was completely unable to produce form I* (Fig. 7, E and F). Taken together with the above results, these experiments indicate that the Glu-21 residue of DnaA plays a crucial role in DnaB helicase loading. This is the first result to identify a unique DnaA domain I residue that is specifically required for DnaB helicase loading. We do not exclude a possibility that this role for Glu-21 may be an indirect consequence, because we do not have direct evidence indicating that Glu-21 directly binds to DnaB.

DnaA E21A Is Active in RIDA—In the RIDA system, which is required to restrain extra, untimely initiations, DnaA-ATP is hydrolyzed when it interacts with Hda that is complexed with the DNA-loaded form of the clamp (3, 35). DnaA domain I is required for this DnaA-ATP hydrolysis (5). We assessed the role for DnaA Glu-21 in this regulation using a reconstituted, staged RIDA system. The DNA-loaded clamps were isolated and were incubated with Hda and ATP-DnaA. The DnaA E21A protein was active in RIDA-specific DnaA-ATP hydrolysis at a level similar to the wild-type DnaA (Fig. 7G). Similar results were obtained for DnaA Q14A and E16A (data not shown). These results highlight the specific role for Glu-21 in helicase loading.


   DISCUSSION
TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
REFERENCES
 
Domain I Dimerization—In this study, we have described the structure of DnaA domain I. DnaA domain I has close structural similarity to the KH domains, including secondary structure topology, i.e. three beta-strands and two or three {alpha}-helices (Fig. 2D). A recently published crystal structure of the KH domain in PCBP2 revealed that it forms homodimers (39) (PDB code: 2AXY). The hydrophobic surface, which is composed of the beta1-strand and {alpha}3-helix in PCBP2, contributes to the dimerization. Similar to the PCBP2 dimer, domain I has a hydrophobic patch that is influenced by salt concentration (Fig. 3). Based on PCBP2 dimer structure and our experimental results, we have proposed a structural model of dimerization between domain I monomers (Fig. 3D). The domain I structure contains a hydrophobic surface within the N-terminal {alpha}1-helix and the loop between beta1 and beta2; based on chemical shift changes, we suggest that this hydrophobic surface, which includes Trp-6, plays an important role in DnaA dimerization (Fig. 3). This is consistent with previous reports that a DnaA W6A mutant protein fails to form homooligomers (17, 18). A considerable part of the Trp-6 side chain is inside of the domain I structure, but some of it is exposed on the surface (Figs. 3C and 5A; supplemental Fig. 1). This structure explains the reduced solubility of DnaA W6A and its role in interactions between DnaA molecules. Previous studies have also indicated that DnaA domain I can form homo-oligomers; for example, the C-terminal domain of the {lambda} cI repressor is required for both self-dimerization and repressor activity, and a hybrid {lambda} cI repressor in which the C-terminal domain has been replaced by the DnaA domain I continues to have repressor activity in vivo (16). We were not able to determine the chemical shift of the N-terminal amino acids Met-1 to Leu-3, because these signals disappeared. This is consistent with the model of the domain I dimer structure in that these residues are located on the dimer interface, thereby causing signal broadening (Fig. 3D).


Figure 6
View larger version (19K):
[in this window]
[in a new window]

  		FIGURE 6.
DnaA E21A is defective in minichromosomal replication in vitro. A–C, we used a minichromosomal replication system reconstituted with purified proteins to assay DnaA initiation activities (see "Experimental Procedures"). A, the indicated amounts of wild-type DnaA (WT) or mutant DnaA Q14A, E16A, or E21A proteins were incubated at 30 °C for 30 min. B, wild-type DnaA and DnaA E21A were preincubated on ice in buffer including 3µM ATP (ATP-WT or ATP-E21A) or ADP (ADP-WT or ADP-E21A), and the indicated amounts were further incubated at 30 °C for 30 min. C, the indicated amounts of the ATP forms of WT DnaA or DnaA E21A were incubated at 30 °C for the indicated times. D, the indicated amounts of WT DnaA and the mutant DnaA Q14A, E16A, and E21A proteins were incubated at 30 °C for 20 min in a minichromosomal replication system with a crude replicative extract. This extract was prepared from the strain WM433 (dnaA204).

 
Interaction with DnaB—We found that DnaA domain I Glu-21 plays a crucial and specific role in DnaB helicase loading. DnaA E21A retains the ability to form an open complex, indicating that the interaction between DnaA molecules and DNA binding are sustained in this mutant. In contrast, DnaA E21A has no activity for loading DnaB onto template DNA. DnaB-interacting regions of DnaA were previously identified by deletion analysis and by functional inhibition using a monoclonal antibody (20, 21, 23). These methods can alter regions neighboring the deletion or bound epitopes, which reduces the resolution of the analysis. For the first time, we have identified a residue specifically required for DnaB loading. Based on this finding and the domain I structure, we suggest that the region including Glu-21 and the N terminus of the {alpha}2-helix is crucial for DnaB loading (Figs. 2B and 3D). This is consistent with previous analyses obtained using truncated forms of DnaA and monoclonal antibodies as described above.

DnaA Multimerization and DnaB Loading on oriC—The sites required for intermolecular DnaA interactions and DnaB loading (Trp-6 and Glu-21, respectively) are located on opposite surfaces of domain I (Figs. 3D and 5A). This is reasonable in that the DnaA-DnaA and DnaA-DnaB interactions must occur simultaneously in the oriC initiation process. The DnaA complex formed by the DnaA R281A protein is unstable on oriC, which results in failure of DnaB loading onto the open complex, although DnaA R281A is active in DnaB loading onto ssDNA in the ABC primosome system (46). Thus, formation of a stable DnaA multimer on oriC is required for DnaB loading onto the open complex. The Arg-281 residue is located in domain III, which most likely forms head-to-tail homomultimers on oriC as it does in several AAA+ proteins (9, 12).


Figure 7
View larger version (37K):
[in this window]
[in a new window]

  		FIGURE 7.
DnaA E21A is defective in DnaB helicase loading. A and B, P1 nuclease assay. The indicated amounts of the ATP or ADP form of the WT DnaA and DnaA E21A (E21A) proteins were incubated at 38 °C in buffer containing oriC plasmid M13KEW101 (320 ng) and HU protein (13 ng) followed by further incubation in the presence of P1 nuclease. DNA was purified, and one-tenth of each sample was digested with AlwNI and analyzed using 1% agarose gel electrophoresis and ethidium bromide staining (A). The intensities of the band signals were quantified, and the amount of P1 nuclease-digested molecules as a percentage of total DNA is shown (B). ATP-WT, ATP-DnaA WT; ADP-WT, ADP-DnaA WT; ATP-E21A, ATP-DnaA E21A; ADP-E21A, ADP-DnaA E21A. C and D, ABC primosome assay. The indicated amounts of WT DnaA and DnaA E21A proteins were incubated at 30 °C for 10 min in buffer containing DnaB helicase, DnaC helicase-loader, single strand-binding protein (500 ng), DNA polymerase III holoenzyme, and M13-A site ssDNA (220 pmol as nucleotides) (C). Similarly, DnaA proteins (0.08 pmol) also were incubated at 30 °C for the indicated times (D). No DnaA, DnaA was not included. E and F, form I* assay. Various amounts of the wild-type DnaA and DnaA E21A proteins were incubated at 30 or 37 °C for 30 min in buffer containing DnaB, DnaC, single strand-binding protein, HU protein, DNA gyrase, and oriC plasmid M13KEW101. DNA was purified and analyzed using 0.7% agarose gel electrophoresis and ethidium bromide staining (E). The migration positions of form I (FI; supercoiled form), form I* (FI*, hyper-supercoiled form), form II (FII; relaxed form), and form III (FIII; linearized form) are indicated. The input form of M13KEW101 was also analyzed (oriC plasmid). The amounts of DnaA used were 0.2, 0.4, 0.6, 0.8, and 1.2 pmol. The intensities of the band signals were quantified, and the amounts of form I* molecules are shown as a percentage of the total DNA (F). G, RIDA-dependent DnaA-ATP hydrolysis. The [{alpha}-32P]ATP forms of the WT DnaA and DnaA E21A proteins (0.25 pmol) were incubated at 30 °C for 20 min in buffer containing the indicated amounts of the DNA-loaded form of the clamp in the presence or absence (-) of Hda (56 fmol). Hydrolysis of DnaA-ATP was quantified and is shown as a percentage.

 
We suggest that domain I forms head-to-head homodimers within the initiation complex through the hydrophobic patch including Trp-6 (Fig. 8). We infer that domain I dimerization is led by rotation of domain I via the domain II flexible linker, which effectively exposes the DnaB interaction site of domain I on the surface of the initiation complex (Fig. 8). DnaB helicase is a homo-hexamer, and at least two DnaB hexamers are loaded onto a single oriC open complex (47, 48). The affinity of DnaA for DnaB is relatively weak; surface plasmon resonance analysis suggests a dissociation constant (Kd) of 2 µM between the two (20). In our model, several sites on DnaA homomultimers that interact with DnaB line up on the surface when the two domains interact, which would be a reasonable way to recruit DnaB efficiently (Fig. 8). In addition, the weak affinity of the domain I of certain DnaA molecules in the open complex might support the interaction between unwound oriC DNA and DnaB helicase by holding the single-stranded region in the vicinity of the DnaB entry site (Fig. 8 and see below). DnaA multimerization on oriC would thus be required for effective interaction with DnaB and for leading DnaB to interact precisely with the limited ssDNA region of unwound oriC.

Although Trp-6 in E. coli DnaA is highly conserved over evolution among DnaA orthologues, conservation of Glu-21 is moderate (supplemental Fig. 2). In addition to Glu, Gln is also moderately conserved at this position. The total conservation of Glu, Gln, and Asp is 71% at this position, implying that these residues use hydrogen bonds for DnaA-DnaB or DnaA-ssDNA interactions.

ssDNA Interaction—Some KH domains, such as those of heterogeneous nuclear ribonucleoprotein K and NusA, repeat several times within a single peptide, and these repeats increase the binding affinity 100–1000-fold (49, 50). Similarly, multimerization of DnaA would increase the overall affinity of domain I for ssDNA. A subset of DnaA molecules in open complex might use this domain for ssDNA interaction (Figs. 3D and 8), contributing to the efficient unwinding of the DNA duplex (Fig. 7B). Like Glu-21, Phe-46 is suggested to interact with ssDNA (Fig. 4C). This residue is highly conserved among DnaA orthologues (supplemental Fig. 2). DnaA domain I has a rigid structure and is connected to domain III via a flexible linker domain II. This overall structure suggests that the function of domain I is basically independent of the other domains. Thus, we infer that the weak affinity of domain I for ssDNA is associated with the full-length protein.


Figure 8
View larger version (29K):
[in this window]
[in a new window]

  		FIGURE 8.
Model of the mechanism of DnaA multimerization and interaction with DnaB. A, schematic presentation of DnaA. DnaA domains I–IV, Glu-21, the hydrophobic patch (HP) including Trp-6, and the second DnaB-binding site on the N terminus of domain III are indicated. B, schematic presentation of the structure of a DnaA multimer on oriC and interaction with DnaB. DnaA domain III forms a head-to-tail multimer. Domain I forms a head-to-head dimers, which causes rotation of the domain to expose Glu-21 on the surface of the DnaA multimer. Thus, a series of DnaB interaction sites form a DnaB entry gate. The unwound ssDNA region may be localized near the DnaB entry site.

 
Several studies of the KH domains using NMR and x-ray structures have indicated that ssDNA interacts with the groove composed of hydrophobic residues and surrounding electrostatic residues (39, 42). Consistent with this finding, the ssDNA-binding surface of domain I contains exposed hydrophobic residues and surrounding electrostatic residues (Fig. 4E). The GXXG motif is a conserved feature in KH domains of various proteins. This motif usually causes a kink in the {alpha}-helix, forming a groove on the protein surface (Fig. 4E, right panel). This groove and the compact side chains of the glycines of the GXXG motif are important for interactions with DNA and RNA (39, 40). The affinity of typical KH domains for DNA and RNA is at the micromolar level. A unique feature of the DnaA domain I is that it does not carry the GXXG motif; instead, Tyr-55, a helix breaker, kinks the {alpha}3-helix (Figs. 1B and 2, B and D). In addition, the N-terminal half of this helix carries bulky and electrostatic side chains (Fig. 4E, left panel), which interrupt the formation of the groove. Therefore the area of ssDNA-binding site within domain I is smaller that that of other KH domains, which most likely causes the weak affinity of domain I for ssDNA.


   FOOTNOTES
 
The atomic coordinates and structure factors (code 2E0G) have been deposited in the Protein Data Bank, Research Collaboratory for Structural Bioinformatics, Rutgers University, New Brunswick, NJ (http://www.rcsb.org/).

* This study was supported by grants-in-aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. Back

Formula The on-line version of this article (available at http://www.jbc.org) contains supplemental Figs. 1–4 and Table 1. Back

{diamondsuit} This article was selected as a Paper of the week. Back

1 Present address: Nipro Medical Co., Kusatsu, Shiga 525-0055, Japan. Back

2 To whom correspondence may be addressed. Tel.: 81-92-642-6641; Fax: 81-92-642-6646; E-mail: katayama{at}phar.kyushu-u.ac.jp. 3 To whom correspondence may be addressed. Tel.: 81-92-642-6662; Fax: 81-92-642-6667; E-mail: ueda{at}phar.kyushu-u.ac.jp.

4 The abbreviations used are: ssDNA, single-stranded DNA; HSQC, heteronuclear single quantum correlation; KH, K homology; NOE, nuclear Overhauser enhancement; NOESY, NOE spectroscopy; PCBP2, poly(C)-binding protein 2; PDB, Protein Data Bank; RIDA, regulatory inactivation of DnaA; r.m.s.d., root mean square deviation; WT, wild type. Back

5 M. Su'etsugu and T. Katayama, unpublished. Back



   REFERENCES
TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 

  1. Kaguni, J. M. (2006) Annu. Rev. Microbiol. 60, 351-375[CrossRef][Medline] [Order article via Infotrieve]
  2. Messer, W. (2002) FEMS Microbiol. Rev. 26, 355-374[Medline] [Order article via Infotrieve]
  3. Katayama, T., Kubota, T., Kurokawa, K., Crooke, E., and Sekimizu, K. (1998) Cell 94, 61-71[CrossRef][Medline] [Order article via Infotrieve]
  4. Kato, J., and Katayama, T. (2001) EMBO J. 20, 4253-4262[CrossRef][Medline] [Order article via Infotrieve]
  5. Su'etsugu, M., Shimuta, T. R., Ishida, T., Kawakami, H., and Katayama, T. (2005) J. Biol. Chem. 280, 6528-6536[Abstract/Free Full Text]
  6. Fujikawa, N., Kurumizaka, H., Nureki, O., Terada, T., Shirouzu, M., Katayama, T., and Yokoyama, S. (2003) Nucleic Acids Res. 31, 2077-2086[Abstract/Free Full Text]
  7. Obita, T., Iwura, T., Su'etsugu, M., Yoshida, Y., Tanaka, Y., Katayama, T., Ueda, T., and Imoto, T. (2002) Biochem. Biophys. Res. Commun. 299, 42-48[CrossRef][Medline] [Order article via Infotrieve]
  8. Yoshida, Y., Obita, T., Kokusho, Y., Ohmura, T., Katayama, T., Ueda, T., and Imoto, T. (2003) Cell. Mol. Life Sci. 60, 1998-2008[CrossRef][Medline] [Order article via Infotrieve]
  9. Erzberger, J. P., Mott, M. L., and Berger, J. M. (2006) Nat. Struct. Mol. Biol. 13, 676-683[CrossRef][Medline] [Order article via Infotrieve]
  10. Erzberger, J. P., Pirruccello, M. M., and Berger, J. M. (2002) EMBO J. 21, 4763-4773[CrossRef][Medline] [Order article via Infotrieve]
  11. Hanson, P. I., and Whiteheart, S. W. (2005) Nat. Rev. Mol. Cell Biol. 6, 519-529[CrossRef][Medline] [Order article via Infotrieve]
  12. Kawakami, H., Keyamura, K., and Katayama, T. (2005) J. Biol. Chem. 280, 27420-27430[Abstract/Free Full Text]
  13. Kawakami, H., Ozaki, S., Suzuki, S., Nakamura, K., Senriuchi, T., Su'etsugu, M., Fujimitsu, K., and Katayama, T. (2006) Mol. Microbiol. 62, 1310-1324[CrossRef][Medline] [Order article via Infotrieve]
  14. Nishida, S., Fujimitsu, K., Sekimizu, K., Ohmura, T., Ueda, T., and Katayama, T. (2002) J. Biol. Chem. 277, 14986-14995[Abstract/Free Full Text]
  15. Indiani, C., and O'Donnell, M. (2006) Nat. Rev. Mol. Cell Biol. 7, 751-761[CrossRef][Medline] [Order article via Infotrieve]
  16. Weigel, C., Schmidt, A., Seitz, H., Tungler, D., Welzeck, M., and Messer, W. (1999) Mol. Microbiol. 34, 53-66[CrossRef][Medline] [Order article via Infotrieve]
  17. Felczak, M. M., Simmons, L. A., and Kaguni, J. M. (2005) J. Biol. Chem. 280, 24627-24633[Abstract/Free Full Text]
  18. Simmons, L. A., Felczak, M., and Kaguni, J. M. (2003) Mol. Microbiol. 49, 849-858[CrossRef][Medline] [Order article via Infotrieve]
  19. Masai, H., Nomura, N., and Arai, K. (1990) J. Biol. Chem. 265, 15134-15144[Abstract/Free Full Text]
  20. Sutton, M. D., Carr, K. M., Vicente, M., and Kaguni, J. M. (1998) J. Biol. Chem. 273, 34255-34262[Abstract/Free Full Text]
  21. Seitz, H., Weigel, C., and Messer, W. (2000) Mol. Microbiol. 37, 1270-1279[CrossRef][Medline] [Order article via Infotrieve]
  22. Marszalek, J., and Kaguni, J. M. (1994) J. Biol. Chem. 269, 4883-4890[Abstract/Free Full Text]
  23. Marszalek, J., Zhang, W., Hupp, T. R., Margulies, C., Carr, K. M., Cherry, S., and Kaguni, J. M. (1996) J. Biol. Chem. 271, 18535-18542[Abstract/Free Full Text]
  24. Robinson, N. P., and Bell, S. D. (2005) FEBS J. 272, 3757-3766[CrossRef][Medline] [Order article via Infotrieve]
  25. Abe, Y., Shodai, T., Muto, T., Mihara, K., Torii, H., Nishikawa, S., Endo, T., and Kohda, D. (2000) Cell 100, 551-560[CrossRef][Medline] [Order article via Infotrieve]
  26. Neri, D., Szyperski, T., Otting, G., Senn, H., and Wuthrich, K. (1989) Biochemistry 28, 7510-7516[CrossRef][Medline] [Order article via Infotrieve]
  27. Grzesiek, S., and Bax, A. (1993) J. Am. Chem. Soc. 115, 12593-12594[CrossRef]
  28. Delaglio, F., Grzesiek, S., Vuister, G. W., Zhu, G., Pfeifer, J., and Bax, A. (1995) J. Biomol. NMR 6, 277-293[Medline] [Order article via Infotrieve]
  29. Deleted in proof
  30. Guntert, P., Mumenthaler, C., and Wuthrich, K. (1997) J. Mol. Biol. 273, 283-298[CrossRef][Medline] [Order article via Infotrieve]
  31. Cornilescu, G., Delaglio, F., and Bax, A. (1999) J. Biomol. NMR 13, 289-302[CrossRef][Medline] [Order article via Infotrieve]
  32. Laskowski, R. A., Rullmannn, J. A., MacArthur, M. W., Kaptein, R., and Thornton, J. M. (1996) J. Biomol. NMR 8, 477-486[Medline] [Order article via Infotrieve]
  33. Deleted in proof
  34. Koradi, R., Billeter, M., and Wuthrich, K. (1996) J. Mol. Graph. 14, 51-55[CrossRef][Medline] [Order article via Infotrieve]
  35. Su'etsugu, M., Takata, M., Kubota, T., Matsuda, Y., and Katayama, T. (2004) Genes Cells 9, 509-522[Abstract/Free Full Text]
  36. Kawakami, H., Su'etsugu, M., and Katayama, T. (2006) J. Struct. Biol. 156, 220-229[Medline] [Order article via Infotrieve]
  37. Holm, L., and Sander, C. (1993) J. Mol. Biol. 233, 123-138[CrossRef][Medline] [Order article via Infotrieve]
  38. Grishin, N. V. (2001) Nucleic Acids Res. 29, 638-643[Abstract/Free Full Text]
  39. Du, Z., Lee, J. K., Tjhen, R., Li, S., Pan, H., Stroud, R. M., and James, T. L. (2005) J. Biol. Chem. 280, 38823-38830[Abstract/Free Full Text]
  40. Nagai, K. (1996) Curr. Opin. Struct. Biol. 6, 53-61[CrossRef][Medline] [Order article via Infotrieve]
  41. Siomi, H., Matunis, M. J., Michael, W. M., and Dreyfuss, G. (1993) Nucleic Acids Res. 21, 1193-1198[Abstract/Free Full Text]
  42. Du, Z., Yu, J., Chen, Y., Andino, R., and James, T. L. (2004) J. Biol. Chem. 279, 48126-48134[Abstract/Free Full Text]
  43. Ishida, T., Akimitsu, N., Kashioka, T., Hatano, M., Kubota, T., Ogata, Y., Sekimizu, K., and Katayama, T. (2004) J. Biol. Chem. 279, 45546-45555[Abstract/Free Full Text]
  44. Hupp, T. R., and Kaguni, J. M. (1993) J. Biol. Chem. 268, 13137-13142